The immune cytokine interleukin 4 has newly recognized effects on skel
etal metabolism. While the interaction of many cells ultimately determ
ines bone mass, we have examined the possibility that the osteoblast m
ay be an IL-4 target in bone by characterizing IL-4 receptor (IL-4R) e
xpression by MC3T3-El (MC3T3) murine osteoblastic cells. Based on I-12
5-IL-4 binding, MC3T3 cells express large numbers of IL-4 receptors (I
-125-IL-4 Bmax = 3,000-7,500 sites/cell, I-125-IL-4 K = 13-40 pM) with
an affinity similar to the IL-4 receptor expressed by an IL-4-respons
ive T cell line. Monoclonal anti-IL-4R antibodies (Ml) blocked specifi
c MC3T3 I-125-IL-4 binding and MC3T3 total cell RNA contained full-len
gth IL-4R mRNA as detected by reverse transcription DNA amplification
utilizing IL-4R primers and Northern blot analysis. Functionally, IL-4
treatment of MC3T3 cells resulted in increased cellular proliferation
(10-20%) and inhibition of alkaline phosphatase levels (20-40%). Whil
e parathyroid hormone (PTH) exposure did not influence IL-4R levels, v
itamin D3 treatment augmented MC3T3 I-125-IL-4 binding, in a time-depe
ndent manner, up to threefold after a 24 h exposure with a metabolite
specificity indicating the involvement of the vitamin D receptor. Equi
librium binding studies showed that the impact of 1,25 (OH)2 D3 on MC3
T3 I-125-IL-4 binding was due to an increased IL-4R Bmax. Cycloheximid
e treatment inhibited 1,25 (OH)2 D3-induced IL-4R upregulation, sugges
ting that protein synthesis was required. Furthermore, the steroid inc
reased steady-state IL-4R mRNA levels in both a time- and concentratio
n-dependent manner. The IL-4R message half-life was not altered by 1,2
5 (OH)2 D3, suggesting that increased IL-4R mRNA expression resulted f
rom increased IL-4R gene transcription. Taken together, these findings
raise the possibility that IL-4's influence on mineral metabolism cou
ld be mediated by osteoblasts and that the effectiveness of this cytok
ine may be influenced by vitamin D3'S impact on IL-4R expression. (C)
1993 Wiley-Liss, Inc.